search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Vertrouwen in de oncoloog.


- candidate number14673
- NTR NumberNTR3934
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR4-apr-2013
- Secondary IDsWO29 / CJ451009; Pink Ribbon / AMC Medical Research
- Public TitleVertrouwen in de oncoloog.
- Scientific TitleBreast cancer patientsí trust in their oncologist: The role of nonverbal behavior and ethnic background.
- ACRONYM
- hypothesis1. Oncologist non-verbal behavior impacts on breast cancer patients' trust;
2. A high amount of eye contact, a patient-oriented posture and regular smiling induce higher trust than low amounts of eye contact, distant posture and a lack of smiling;
3. Immigrant breast cancer patients report lower trust in the oncologist overall;
4. Non-verbal behaviors, i.e., more eye contact, patient-oriented posture and more smiling, enhance trust more strongly in immigrant patients than in other patients.
- Healt Condition(s) or Problem(s) studiedBreast cancer
- Inclusion criteria1. A previous breast cancer diagnosis, not currently in active treatment, or;
2. Healthy woman between 18 and 75 years of age, or;
3. Dutch or Western background, or;
4. Non-Western immigrant background.
- Exclusion criteria1. <18 years;
2. Serious mental disorders.
- mec approval receivedno
- multicenter trialno
- randomisedyes
- masking/blindingSingle
- controlActive
- groupFactorial
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-nov-2013
- planned closingdate31-dec-2014
- Target number of participants300
- InterventionsNonverbal behavior of an oncologist observed in a video-recorded consultation:
1. Oncologist amount of eye contact (high vs low);
2. Oncologist bodily posture (patient oriented vs distant);
3. Oncologist facial expression (smiling vs serious).
- Primary outcomePatient trust in the observed oncologist, assessed with the Trust in Oncologist Scale.
- Secondary outcome1. Patient satisfaction with the observed consultation;
2. Patient willingness to recommend the oncologist;
3. Patient's wish to stay with the oncologist.
- TimepointsDirectly after video observation.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIESMs. Marij Hillen
- CONTACT for SCIENTIFIC QUERIESMs. Marij Hillen
- Sponsor/Initiator Academic Medical Center (AMC, Amsterdam)
- Funding
(Source(s) of Monetary or Material Support)
Pink Ribbon
- PublicationsN/A
- Brief summaryFor breast cancer patients, it is of paramount importance to trust their oncologist. Breast cancer is associated with an uncertain prognosis, and treatment having a severe impact on a patientís life. To cope with these adversities, patients are strongly dependent on their oncologist. Trust between patients and their oncologist is therefore crucial for good quality breast cancer care. Indeed, more trust is associated with beneficial outcomes, such as a decrease in patientsí fear and better adherence. Currently, however, we have little insight into the strength of breast cancer patientsí trust. Moreover, there is limited knowledge of whether and how trust levels differ across patientsí ethnic backgrounds.

In order to maximize trust, we need to know how such trust develops. Essential for the establishment of trust is the communication, both verbal and nonverbal, between breast cancer patients and their oncologist. How the oncologistís verbal communication impacts on trust is currently being studied. Preliminary evidence, however, suggests that verbal factors explain only a small part of patientsí trust. Nonverbal communication might have a much stronger influence on patientsí perception of the conversation. To date, the impact of the oncologistís nonverbal communication on patientsí trust has not been investigated. Some evidence suggests that nonverbal behaviors might be perceived differently by patients from different ethnic backgrounds, but this requires further examination. In the proposed study, we will first investigate the levels of breast cancer patientsí trust. Next, the impact of the oncologistís nonverbal behavior on breast cancer patientsí trust will be studied. Moreover, we will examine whether trust levels and the impact of nonverbal behavior on trust are different for Western patients than for ethnic minority patients.

To this end, we conduct a survey study combined with a quasi-experimental video-vignettes study. Breast cancer patients and healthy participants with Western as well as ethnic minority backgrounds will be recruited in The Netherlands to participate in these studies. In the survey study (Study 1), background characteristics of all participants will be assessed. Moreover, breast cancer patients will fill in the Trust in Oncologist Scale, assessing trust in their treating oncologist. The video-vignettes study (Study 2) will have a 2 x 2 design. We will manipulate two particularly salient elements of nonverbal communication, i.e. (1) the eye-contact the oncologist seeks with the patient and (2) the oncologistís posture, and specifically, his or her tranquility. For both nonverbal behaviors, two different conditions will be created in which the oncologistís amount of eye contact and tranquility will be manipulated. We will investigate the effect of these manipulations on trust. First, for Study 1, participants will fill in the questionnaire. Then, for Study 2, they will watch the video vignettes while imagining themselves in the position of the patient. Finally, trust in the observed oncologist will be assessed.

This study will provide more insight into the strength of breast cancer patientsí trust, and variations therein. Moreover, it will generate knowledge about the relevant factors of oncologist communication on breast cancer patientsí trust. This knowledge can be applied in the education of medical students and oncologists (in training), and will thus ultimately improve breast cancer patient care, both during treatment and in follow-up.
- Main changes (audit trail)
- RECORD4-apr-2013 - 11-apr-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl